As of 2024-09-20, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (61.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.12 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -770.7%.
The range of the Relative Valuation is (66.19) - (56.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.5x - 49.5x | 37.2x |
| Forward P/E multiples | 20.2x - 27.9x | 22.8x |
| Fair Price | (66.19) - (56.89) | (61.17) |
| Upside | -825.7% - -723.8% | -770.7% |
| Date | P/E |